Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle L McCully

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Nature Medicine|May 26, 2009
Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndromeThu A Chau, Michelle L McCully, William Brintnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2018
CCR8 Expression Defines Tissue-Resident Memory T Cells in Human SkinMichelle L McCully, Kristin Ladell, Robert Andrews, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2017
Epithelial chemokine CXCL14 synergizes with CXCL12 <i>via</i> allosteric modulation of CXCR4Paul J Collins, Michelle L McCully, Laura Martínez-Muñoz, et al.
JCI Insight|September 7, 2021
Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitorsAdam P Curnock, Giovanna Bossi, Jyothi Kumaran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2020
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA ComplexCharlotte H Coles, Rachel M Mulvaney, Sunir Malla, et al.
Hepatology (Baltimore, Md.)|August 10, 2020
Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected CellsJoannah R Fergusson, Zoë Wallace, Mary M Connolly, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2024
An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosisRachel L Paterson, Marco P La Manna, Victoria Arena De Souza, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Medicine|May 26, 2009
Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndromeThu A Chau, Michelle L McCully, William Brintnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2018
CCR8 Expression Defines Tissue-Resident Memory T Cells in Human SkinMichelle L McCully, Kristin Ladell, Robert Andrews, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2017
Epithelial chemokine CXCL14 synergizes with CXCL12 <i>via</i> allosteric modulation of CXCR4Paul J Collins, Michelle L McCully, Laura Martínez-Muñoz, et al.
JCI Insight|September 7, 2021
Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitorsAdam P Curnock, Giovanna Bossi, Jyothi Kumaran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2020
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA ComplexCharlotte H Coles, Rachel M Mulvaney, Sunir Malla, et al.
Hepatology (Baltimore, Md.)|August 10, 2020
Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected CellsJoannah R Fergusson, Zoë Wallace, Mary M Connolly, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2024
An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosisRachel L Paterson, Marco P La Manna, Victoria Arena De Souza, et al.
Pageof 2